Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Neural Regulation01:37

Neural Regulation

39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Targeted α-synuclein mRNA degradation by PMO-based RNA-degrading chimeras.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same authorSame journal

A Randomized Controlled Trial of Dual Upper-Extremity Training [DUET]: Combining Neurologic Music Therapy® with Noninvasive Brain Stimulation for Upper-Limb Performance in Corticobasal Syndrome.

Movement disorders clinical practice·2026
Same author

<i>LRRK2</i> in Focus: A Global Browser Linking Genetic Diversity to Functional Effects.

medRxiv : the preprint server for health sciences·2026
Same author

Striatal Tau Pathology Underlies Monoaminergic Disruption in Progressive Supranuclear Palsy.

Clinical nuclear medicine·2026
Same author

Regional wasteosome accumulation across neurodegenerative diseases points to a shared underlying mechanism potentially related to glymphatic insufficiency.

Acta neuropathologica communications·2026
Same author

Repeat expansions in Parkinson's disease and parkinsonism across ancestries: insights from a global genetic cohort.

medRxiv : the preprint server for health sciences·2026

相关实验视频

Updated: Sep 9, 2025

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.9K

逐步超核性麻 - 全球综述

Prashanth Lingappa Kukkle1, Rosy Neupane1, Alexandar Pantelyat2

  • 1Parkinson's Disease and Movement Disorders Clinic, Bangalore, India.

Movement disorders clinical practice
|September 3, 2025
PubMed
概括

渐进性超核性 (PSP) 在流行和表现方面呈现出显著的全球差异. 解决诊断和护理方面的区域差异对于改善全球患者的结果至关重要.

关键词:
公共服务研究小组临床情况全球比较渐进的超核性

更多相关视频

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

10.0K
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.3K

相关实验视频

Last Updated: Sep 9, 2025

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.9K
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

10.0K
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.3K

科学领域:

  • 神经科学
  • 流行病学
  • 遗传学

背景情况:

  • 渐进性超核性 (PSP) 是一种罕见的严重神经退行性病,具有多种临床表型.
  • 在PSP流行,临床表现和预后方面存在显著的地理差异.

研究的目的:

  • 系统地审查全球流行病变异,临床表型,诊断实践和PSP的管理策略.
  • 找出区域差异以及影响PSP的遗传和环境因素.

主要方法:

  • 根据PRISMA指南进行全面的文献搜索.
  • 对PSP流行病学,表型,诊断,危险因素,治疗和预后的研究进行分析.
  • 根据地理位置分类的数据,考虑到区域差异.

主要成果:

  • 全球PSP患病率为每10万人中5-6.4,受诊断标准和医疗保健基础设施的影响.
  • 常见的PSP症状包括视力,跌倒,认知和运动功能障碍.
  • 预后因亚型而异 (例如,PSP-RS 5-7年,PSP-P 8-12年);遗传学 (MAPT H1亚型),环境和医疗保健获得的区域差异.

结论:

  • 在PSP流行,表型和医疗保健的区域差异需要标准化的诊断标准.
  • 有针对性的遗传/环境研究和公平的医疗保健策略至关重要.
  • 加强全球合作对于改善PSP诊断,管理和结果至关重要.